Table 2.
Post-operative outcomes in both groups at 6 months
| Outcome | Group A | Group B | p value |
|---|---|---|---|
| N = 30 | N = 30 | ||
| LogMAR BCVA | |||
| Range | (0.3–0.9) | (0.6–1) | < 0.001* |
| Mean ± SD | 0.6 ± 0.2 | 0.9 ± 0.15 | |
| CMT | |||
| Range | (162–350) | (209–334) | 0.987 |
| Mean ± SD | 262.1 ± 54.4 | 262.3 ± 38.7 | |
| VD-SCP | |||
| Range | (35.29–51.53) | (30.11–52) | 0.046* |
| Mean ± SD | 44.8 ± 6.4 | 41.7 ± 5.5 | |
| VD-DCP | |||
| Range | (31.5–53.1) | (30.1–53.1) | 0.674 |
| Mean ± SD | 42.3 ± 5.8 | 41.7 ± 5.4 | |
| ERM | |||
| No. (%) | 4 (13.3%) | 0 (0%) | 0.04* |
| Dimples | |||
| No. (%) | 0 (0%) | 16 (53.3%) | < 0.001* |
| P1 amplitude | |||
| Mean ± SD | 40.1 ± 9.8 | 30.9 ± 11.8 | 0.002* |
BCVA best-corrected visual acuity, CMT central macular thickness, VD-SCP vessel density of superficial capillary plexus, VD-DCP vessel density of deep capillary plexus, ERM epiretinal membrane
* Italic type indicates statistical significance